glp-1 agonists marketing strategies 2025 The effect on MedTech Monster of 2025: GLP-1 Ads

Haschka, J

Different drugs performed better in different areas, but all 15 GLP-1RAs they analyzed were very successful in lowering blood glucose and achieving weight loss

From what we know now, it would significantly raise the cost of coverage for our employer groups and our members, says Matt Burns, chief actuary at Blue Cross and Blue Shield of Kansas

& Pyke, C

Needle gauge requirements vary by product but are not believed to be the main factor affecting patient preference (39)

Holland, MD, MS, lead author, total joint arthroplasty surgeon at Campbell Clinic Orthopaedics and a faculty instructor at the University of Tennessee Health Science Center in Memphis